newsfilter
← Latest News
Business Wire·

CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare